Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 2 of the last 4 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 33 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
MEDICINA LEGATIS from Anderlecht, company number BE0768452509, closed financial year 2025 with a result of € 10,983 after tax. For that financial year MEDICINA LEGATIS recorded revenue of € 170,012 and equity of € -12,716. Compared with financial year 2024, the result moved from € -30,231 to € 10,983. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 3, 2026.
€ -12,716
▲ € 10,983 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 10,983
▲ still € 30,231 loss in 2024
Profit after tax over the fiscal year.
€ 9,052
▲ € 8,146 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -20,716.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 47,169
▲ 198% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 912
▼ 92% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | - | - | - | € 170,012 | |
| Gross margin | € 1,559 | € 1,763 | € -27,258 | € 17,017 | ▲ € 44,275 |
| Profit after taxes | € -1,562 | € 94 | € -30,231 | € 10,983 | ▲ € 41,214 |
| Equity | € 6,438 | € 6,532 | € -23,699 | € -12,716 | ▲ € 10,983 |
| Total debts | € 18,700 | € 4,580 | € 53,098 | € 74,081 | ▲ 40% |
| Cash | € 412 | € 4,119 | € 906 | € 9,052 | ▲ € 8,146 |
| Retained profit | € -1,562 | € -1,468 | € -31,699 | € -20,716 | ▲ € 10,983 |
| Balance sheet total | € 25,138 | € 11,112 | € 29,399 | € 61,365 | ▲ 109% |
Key figures of MEDICINA LEGATIS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to MEDICINA LEGATIS?
What happened at MEDICINA LEGATIS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 10,983. Source: NBB ↗
- Bertrand VELDEKENS became a director. NBB
- William SUN became a director. NBB
- S.S.M. sa became a director. NBB
- New establishment in Anderlecht. KBO
- Start of the company according to the CBE. KBO
- Frédéric SCHUIND became a director. NBB
In short
From € 1,562 loss in 2022 to € 10,983 profit in 2025.
Best year ever: 2025, with € 10,983 profit.
A new publication or filing at MEDICINA LEGATIS? We notify you, reason included.
Follow MEDICINA LEGATISDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind MEDICINA LEGATIS are Frédéric SCHUIND, Bertrand VELDEKENS, William SUN and S.S.M. sa.
Directors
According to the 2025 annual accounts
Frédéric SCHUIND
Director
since 2021
Bertrand VELDEKENS
Director
since 2024
William SUN
Director
since 2024
Managing director · represented by Benoît STAINIER
since 2024
Establishments
Establishment units
Physical locations of this company
Seringenlaan 21 box 23
1070 Anderlecht
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0768.452.509
- VAT number
- BE 0768.452.509
- Registered office
- Seringenlaan 21 bus 23, 1070 Anderlecht
- Names & denominations
- MEDICINA LEGATIS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 17 May 2021
- Peppol
- Active · Active since 8 Oct 2025
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Handelsbemiddeling in de groothandel in andere specifieke goederen
Vervaardiging van overige farmaceutische producten
Handelsbemiddeling in de groothandel in meubelen, huishoudelijke artikelen en ijzerwaren
Groothandel in farmaceutische en medische artikelen
Overige dienstverlenende activiteiten op het gebied van informatie
Overige dienstverlenende activiteiten op het gebied van informatie, n.e. g.